# US 11,078,496 B2 · System for F-box hormone receptor regulated protein expression in mammalian cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 11,078,496 B2
- Document ID: US11078496B2
- Status: Granted
- Kind: B2
- Application number: 16/093,436
- Filed: 2017-04-12
- Published: 2019-10-17
- Granted: 2021-08-03
- Earliest claimed: 2016-04-12
- Assignees: Icahn School of Medicine at Mount Sinai; University of Washington through its Center for Commercialization
- Applicants: Icahn School of Medicine At Mount Sinai; University of Washington Through Its Center for Commercialization
- Inventors: Ran Brosh, Sr.; Ihor R. Lemischka; Ning Zheng
- Web page: https://patentgrep.com/patent/US11078496B2

## CPC

- C12N 15/63: Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N 15/86: Viral vectors
- A61K 48/0066: {Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid}
- A61K 48/0083: {characterised by an aspect of the administration regime}
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- C12N 15/79: Vectors or expression systems specially adapted for eukaryotic hosts
- C12N 2799/02: as vector
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to a system for F-box hormone receptor regulated protein expression in mammalian cells. The system includes a silencing nucleic acid molecule comprising a first promoter and an shRNA operably linked to the first promoter, where the shRNA silences expression of a target protein. The system also includes an expression nucleic acid molecule comprising a second promoter, an F-box hormone receptor operably linked to the second promoter, and a nucleic acid molecule encoding a fusion protein comprising a degron fused to the target protein, where the nucleic acid molecule encoding the fusion protein is operably linked to the second promoter. Also disclosed are vectors comprising the system of the present application and methods of use thereof.

## Claims

### Claim 1

A system for F-box hormone receptor regulated protein expression, said system comprising:
a silencing nucleic acid molecule comprising a first promoter and an shRNA operably linked to the first promoter, wherein the shRNA silences expression of a target protein; and
an expression nucleic acid molecule comprising a second promoter, an F-box hormone receptor operably linked to the second promoter, and a nucleic acid molecule encoding a fusion protein comprising an auxin induced degradation (AID) degron fused to the target protein, wherein the nucleic acid molecule encoding the fusion protein is operably linked to the second promoter.

### Claim 2 (depends on 1)

The system of claim 1, wherein the first promoter is an RNA polymerase III promoter.

### Claim 3 (depends on 1)

The system of claim 1, wherein the first promoter is a U6 promoter.

### Claim 4 (depends on 1)

The system of claim 1, wherein the shRNA targets the 3′-UTR of the target protein.

### Claim 5 (depends on 1)

The system of claim 1, wherein the shRNA targets a coding region of the target protein.

### Claim 6 (depends on 1)

The system of claim 1, wherein the fusion protein is resistant to silencing by the shRNA.

### Claim 7 (depends on 1)

The system of claim 1, wherein the second promoter is an RNA polymerase II promoter.

### Claim 8 (depends on 1)

The system of claim 1, wherein the F-box hormone receptor is codon-optimized for expression in mammalian cells.

### Claim 9 (depends on 1)

The system of claim 1, wherein the F-box hormone receptor is an auxin receptor.

### Claim 10 (depends on 1)

The system of claim 1, wherein the F-box hormone receptor is Transport Inhibitor Response 1 (TIR1).

### Claim 11 (depends on 1)

The system of claim 1, wherein the F-box hormone receptor is a chimeric F-box hormone receptor.

### Claim 12 (depends on 1)

The system of claim 1, wherein the fusion protein comprises a target protein fused to the amino-terminus of the auxin induced degradation (AID) degron.

### Claim 13 (depends on 1)

The system of claim 1, wherein the fusion protein comprises a target protein fused to the carboxyl-terminus of the auxin induced degradation (AID) degron.

### Claim 14 (depends on 1)

The system of claim 1, wherein the expression nucleic acid molecule further encodes:
a selectable marker operably linked to the second promoter.

### Claim 15 (depends on 14)

The system of claim 14, wherein the expression nucleic acid molecule further encodes:
a first self-cleaving peptide between the F-box hormone receptor and the fusion protein and a second self-cleaving peptide between the fusion protein and the selectable marker.

### Claim 16 (depends on 1)

A vector comprising the system of claim 1, wherein the silencing nucleic acid molecule is coupled directly or indirectly to the expression nucleic acid molecule.

### Claim 17 (depends on 16)

A mammalian cell infected with the vector of claim 16.

### Claim 18 (depends on 1)

A method for F-box hormone receptor regulated protein degradation in a mammalian host cell comprising:
providing a mammalian host cell;
introducing the system of claim 1 into the mammalian host cell to produce a transgenic mammalian host cell;
culturing said transgenic mammalian host cell under conditions that result in (i) silencing expression of the target protein and (ii) expression of the fusion protein; and
contacting said transgenic mammalian host cell with a molecule that binds the F-box hormone receptor so that said fusion protein undergoes degradation.

### Claim 19

A method for F-box hormone receptor regulated target protein degradation in a mammalian host cell comprising:
providing a mammalian host cell;
infecting, into the mammalian host cell, a first lentiviral vector comprising (i) a first silencing nucleic acid molecule comprising a primary first promoter and a first shRNA operably linked to the primary first promoter, wherein the first shRNA silences expression of a first target protein and (ii) a first expression nucleic acid molecule comprising a primary second promoter, a Transport Inhibitor Response 1 (TIR1) receptor operably linked to the primary second promoter, and a nucleic acid molecule encoding a first fusion protein comprising an auxin-induced degradation (AID) degron fused to a first target protein, wherein the nucleic acid molecule encoding the first fusion protein is operably linked to the primary second promoter;
infecting, into the mammalian host cell, a second lentiviral vector comprising (i) a second silencing nucleic acid molecule comprising a secondary first promoter and a second shRNA operably linked to the secondary first promoter, wherein the second shRNA silences expression of a second target protein and (ii) a second expression nucleic acid molecule comprising a secondary second promoter, a Coronatine Insensitive 1 (COI1 receptor operably linked to the secondary second promoter, and a nucleic acid molecule encoding a second fusion protein comprising a jasmonate ZIM-domain (JAZ) degron fused to a second target protein, wherein the nucleic acid molecule encoding the second fusion protein is operably linked to the secondary second promoter;
culturing said infected mammalian host cell under conditions that result in (i) silencing expression of the first and second target proteins and (ii) expression of the first and second fusion proteins;
contacting said infected mammalian host cell with a molecule that binds the TIR1 receptor so that said first fusion protein undergoes degradation; and
contacting said infected mammalian host cell with a molecule that binds the COI1 receptor so that said second fusion protein undergoes degradation.

### Claim 20 (depends on 1)

The system of claim 1, wherein the auxin induced degradation (AID) degron comprises amino acids 63-109 of SEQ ID NO: 3 (AID47).

### Claim 21 (depends on 1)

The system of claim 1, wherein the auxin induced degradation (AID) degron consists of amino acids 63-109 of SEQ ID NO: 3 (AID47).

### Claim 22 (depends on 8)

The system of claim 8, wherein the F-box hormone receptor is a plant F-box hormone receptor.